|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||
| Current assets: | ||||||||||||||
| Short-term investments | ||||||||||||||
| Cash, cash equivalents and restricted cash | ||||||||||||||
| Marketable securities | ||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||
| Total current assets | ||||||||||||||
| Property and equipment, net | ||||||||||||||
| Right of use assets | ||||||||||||||
| Long-term investments | ||||||||||||||
| Other assets | ||||||||||||||
| Total Other Assets | ||||||||||||||
| Total Assets | ||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||
| Accrued payroll and payroll taxes | ||||||||||||||
| Accrued interest payable - director and shareholders | ||||||||||||||
| Lease liabilities, current portion | ||||||||||||||
| Convertible notes payable - shareholders, current portion | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Lease liabilities, long-term portion | ||||||||||||||
| Total liabilities | ||||||||||||||
| Stockholders’ equity: | ||||||||||||||
| Common stock, par value $0.001, 200,000,000 shares authorized; 45,103,461 and 38,139,144 shares issued and outstanding, respectively | ||||||||||||||
| Treasury stock, 433,333 shares, at cost | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||
| Accumulated deficit | ||||||||||||||
| Total stockholders’ equity | ||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||
Loading...